| Fees from tissue distribution | |
| Other revenues | |
| Total revenues | 66.55M |
| Costs of processing and distribution | 32.27M |
| Gross profit | 34.27M |
| Marketing, general and administrative | 28.72M |
| Research and development | 3.79M |
| Asset abandonments | |
| Total operating expenses | 37.6M |
| Operating income | -3.32M |
| Interest expense | -308K |
| Interest income | 1K |
| Foreign exchange (loss) gain | -67K |
| Total other expense - net | -374K |
| Income before income tax provision | |
| Income tax provision | 92K |
| Net income | |
| Net income per common share - basic | -0.08 |
| Net income per common share - diluted | -0.08 |
| Weighted average shares outstanding - basic | 58.35M |
| Weighted average shares outstanding - diluted | 58.35M |